Freenome
Biotech company developing multi-omics blood tests for early cancer detection using AI
About Freenome
Freenome is a biotechnology company developing blood-based tests for the early detection of cancer. Its research platform combines multiple types of biological data with computational biology and machine learning to identify signals that may be associated with cancer, with an initial clinical focus on colorectal cancer screening. The companyβs multiomics approach is built around analyzing both tumor-derived and non-tumor signals in blood rather than relying on a single biomarker. Freenome has advanced its colorectal cancer test through large clinical research programs and is working to develop additional screening tests and future generations of its diagnostic pipeline. For healthcare professionals and researchers following blood tests for cancer screening, early colorectal cancer detection, liquid biopsy research, and AI-enabled diagnostics, Freenome is developing technology intended to make screening more accessible. Its work applies machine learning and multiomics science to the challenge of detecting cancer-related signals before symptoms prompt diagnostic evaluation.
AI Tools & Services
No AI tools listed yet.
Reviews
No reviews yet.
Similar AI Companies
Hadrian
Autonomous manufacturing company using AI and advanced robotics for precision aerospace parts
Fictiv
Digital manufacturing ecosystem using AI to streamline hardware development and sourcing
Hubs
Digital manufacturing platform using AI to connect designers with a global network of suppliers
Xometry
On-demand manufacturing platform using AI to instantly price and route custom parts